| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.26 | 7e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.26 | 1e-06 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-06 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.21 | 9e-06 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.12 | 6e-05 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |